FDA 483 - PPD Development, L.P. - May 14, 2026

An FDA inspection of PPD Laboratories, GMP Lab in Middleton, WI, a biopharmaceuticals analytical facility, revealed a significant quality control issue. The firm used an expired reference standard in multiple studies without providing any justification for its continued use. This indicates a potential lapse in quality control and adherence to good manufacturing practices.